Matches in SemOpenAlex for { <https://semopenalex.org/work/W1923016371> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W1923016371 endingPage "90" @default.
- W1923016371 startingPage "481" @default.
- W1923016371 abstract "For decades, high-dose intravenous cyclophosphamide (ivCY) given for 24-30 months was regarded as the standard therapy for proliferative lupus nephritis, despite serious side effects. Our aim was to evaluate the effect of induction therapy with short-term high-dose ivCY followed by mycophenolate mofetil (MMF) on disease parameters, mortality and health-related quality of life (HRQoL) in patients with proliferative lupus nephritis.Between January 2003 and November 2006, 71 patients with biopsy-proven proliferative lupus nephritis were included in the second Dutch Lupus Nephritis Study. All patients were treated with ivCY (750 mg÷m2, six monthly pulses) plus oral prednisone, followed by MMF (2000 mg÷day) plus oral prednisone for 18 months, and then azathioprine (2 mg÷kg÷day) plus oral prednisone. Study endpoints included the occurrence of renal relapse, end-stage renal disease (ESRD) and mortality.After a median follow-up of 3.8 years (range 0.1-4.5), four (5.6%) of the 71 patients had a renal relapse, one (1.4%) failed treatment, one (1.4%) reached ESRD, and two (2.8%) died. Systemic lupus erythematosus (SLE) Disease Activity Index, serum creatinine, proteinuria and antibodies against anti-dsDNA decreased significantly during treatment and serum levels of complement factor 3 and 4 increased significantly. Furthermore, six of eight domains of the Short Form-36 as well as the number of symptoms and total distress level according to the SLE Symptom Checklist improved significantly over time.This open-label study shows that induction therapy with short-term (six monthly pulses) high-dose ivCY followed by MMF is effective in preventing renal relapses, ESRD and mortality and improving HRQoL in patients with proliferative lupus nephritis." @default.
- W1923016371 created "2016-06-24" @default.
- W1923016371 creator A5007054038 @default.
- W1923016371 creator A5014634963 @default.
- W1923016371 creator A5039265980 @default.
- W1923016371 creator A5045731739 @default.
- W1923016371 creator A5046964429 @default.
- W1923016371 creator A5057020836 @default.
- W1923016371 creator A5072290056 @default.
- W1923016371 creator A5075648330 @default.
- W1923016371 date "2014-11-01" @default.
- W1923016371 modified "2023-10-03" @default.
- W1923016371 title "Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis." @default.
- W1923016371 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25431394" @default.
- W1923016371 hasPublicationYear "2014" @default.
- W1923016371 type Work @default.
- W1923016371 sameAs 1923016371 @default.
- W1923016371 citedByCount "7" @default.
- W1923016371 countsByYear W19230163712015 @default.
- W1923016371 countsByYear W19230163712016 @default.
- W1923016371 countsByYear W19230163712017 @default.
- W1923016371 countsByYear W19230163712022 @default.
- W1923016371 countsByYear W19230163712023 @default.
- W1923016371 crossrefType "journal-article" @default.
- W1923016371 hasAuthorship W1923016371A5007054038 @default.
- W1923016371 hasAuthorship W1923016371A5014634963 @default.
- W1923016371 hasAuthorship W1923016371A5039265980 @default.
- W1923016371 hasAuthorship W1923016371A5045731739 @default.
- W1923016371 hasAuthorship W1923016371A5046964429 @default.
- W1923016371 hasAuthorship W1923016371A5057020836 @default.
- W1923016371 hasAuthorship W1923016371A5072290056 @default.
- W1923016371 hasAuthorship W1923016371A5075648330 @default.
- W1923016371 hasConcept C126322002 @default.
- W1923016371 hasConcept C203014093 @default.
- W1923016371 hasConcept C2776694085 @default.
- W1923016371 hasConcept C2776755627 @default.
- W1923016371 hasConcept C2776760755 @default.
- W1923016371 hasConcept C2776912625 @default.
- W1923016371 hasConcept C2778720950 @default.
- W1923016371 hasConcept C2779134260 @default.
- W1923016371 hasConcept C2779561371 @default.
- W1923016371 hasConcept C2779912601 @default.
- W1923016371 hasConcept C2780091579 @default.
- W1923016371 hasConcept C2780306776 @default.
- W1923016371 hasConcept C71924100 @default.
- W1923016371 hasConcept C90924648 @default.
- W1923016371 hasConceptScore W1923016371C126322002 @default.
- W1923016371 hasConceptScore W1923016371C203014093 @default.
- W1923016371 hasConceptScore W1923016371C2776694085 @default.
- W1923016371 hasConceptScore W1923016371C2776755627 @default.
- W1923016371 hasConceptScore W1923016371C2776760755 @default.
- W1923016371 hasConceptScore W1923016371C2776912625 @default.
- W1923016371 hasConceptScore W1923016371C2778720950 @default.
- W1923016371 hasConceptScore W1923016371C2779134260 @default.
- W1923016371 hasConceptScore W1923016371C2779561371 @default.
- W1923016371 hasConceptScore W1923016371C2779912601 @default.
- W1923016371 hasConceptScore W1923016371C2780091579 @default.
- W1923016371 hasConceptScore W1923016371C2780306776 @default.
- W1923016371 hasConceptScore W1923016371C71924100 @default.
- W1923016371 hasConceptScore W1923016371C90924648 @default.
- W1923016371 hasIssue "9" @default.
- W1923016371 hasLocation W19230163711 @default.
- W1923016371 hasOpenAccess W1923016371 @default.
- W1923016371 hasPrimaryLocation W19230163711 @default.
- W1923016371 hasRelatedWork W1886500020 @default.
- W1923016371 hasRelatedWork W2007687382 @default.
- W1923016371 hasRelatedWork W2044770659 @default.
- W1923016371 hasRelatedWork W2065928084 @default.
- W1923016371 hasRelatedWork W2110249745 @default.
- W1923016371 hasRelatedWork W2255795953 @default.
- W1923016371 hasRelatedWork W2541985720 @default.
- W1923016371 hasRelatedWork W3045673872 @default.
- W1923016371 hasRelatedWork W3122885271 @default.
- W1923016371 hasRelatedWork W83593718 @default.
- W1923016371 hasVolume "72" @default.
- W1923016371 isParatext "false" @default.
- W1923016371 isRetracted "false" @default.
- W1923016371 magId "1923016371" @default.
- W1923016371 workType "article" @default.